Combining TF profiling and in vitro TAM differentiation assays, we confirmed that PPARγ is a driving molecule of the terminal differentiation of MMP9+ TAMs and subsequently promotes HCC progression. This evidence concerns the gene MMP9 and hepatocellular carcinoma.